angiogenesis Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 1 (1)

Interventional (1)

Shanghai Jiao Tong University School of Medicine (1)

No (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadcarcinoma

I am/have/hadrenal function

I am/have/hadsquamous cell carcinoma of the head and neck

I am/have/hadvegf

I am/have/hadsquamous cell carcinoma

I am/have/hadneovascularization

I am/have/hadtargeted therapy

I am/have/hadhypoxia

I am/have/hadchemoradiotherapy

I am/have/hadcancer

I am/have/hadwhite blood cell count

I am/have/hadlymph node metastases

I am/have/hadvascular endothelial growth factor

I am/have/hadimmunosuppression

I am/have/hadleukocyte count

I am/have/hadmetastasis

I am/have/hadhead and neck squamous cell carcinoma

I am/have/hadtumor angiogenesis

I am/have/hadangiogenesis

I am/have/hadvascular endothelial growth factor receptor 2

added new label for I am/have/had

more

I am looking for

I am looking forapatinib

I am looking forvascular endothelial growth factor

I am looking forvegf

I am looking forimmune checkpoint inhibitor

I am looking forgrowth factor

I am looking forcamrelizumab

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 1
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Dental/Oral Health
Recruiting

Inductive Camrelizumab and Apatinib for Patients With Locally Advanced and Resectable Oral Squamous Cell Carcinoma

After tumor hypoxia, high expression of VEGF will induce tumor cells to express programmed cell death protein-1 (PD-1), which further leads to immune escape. Targeted drugs against angiogenesis can relieve immunosuppression to a certain extent, and theoretically have a synergistic effect with anti-PD-1 immunotherapy.

carcinoma

renal function

squamous cell carcinoma of the head and neck

immune checkpoint inhibitor

vegf

0 views
05 Aug, 2020

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.